# Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery

> **NCT02548715** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Hypothyroidism
- Neoplasms
- Postoperative Complications

## Interventions

- **DRUG:** Levothyroxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02548715
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548715, "Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02548715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*